Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback